CN104711279B - 一种血管内皮生长因子检测试剂盒及其原料制备 - Google Patents
一种血管内皮生长因子检测试剂盒及其原料制备 Download PDFInfo
- Publication number
- CN104711279B CN104711279B CN201510115025.0A CN201510115025A CN104711279B CN 104711279 B CN104711279 B CN 104711279B CN 201510115025 A CN201510115025 A CN 201510115025A CN 104711279 B CN104711279 B CN 104711279B
- Authority
- CN
- China
- Prior art keywords
- vegf
- adjuvant
- mouse
- holes
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 title claims abstract description 44
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 title claims abstract description 43
- 238000001514 detection method Methods 0.000 title abstract description 11
- 239000002994 raw material Substances 0.000 title abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 17
- 230000003053 immunization Effects 0.000 claims abstract description 5
- 238000002649 immunization Methods 0.000 claims abstract description 5
- 239000000427 antigen Substances 0.000 claims description 10
- 239000007924 injection Substances 0.000 claims description 10
- 238000002347 injection Methods 0.000 claims description 10
- 102000036639 antigens Human genes 0.000 claims description 9
- 108091007433 antigens Proteins 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 8
- 102000058223 human VEGFA Human genes 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 8
- 206010003445 Ascites Diseases 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 230000014509 gene expression Effects 0.000 claims description 6
- 230000028993 immune response Effects 0.000 claims description 6
- 238000007920 subcutaneous administration Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 108010090804 Streptavidin Proteins 0.000 claims description 5
- 108020001507 fusion proteins Proteins 0.000 claims description 5
- 102000037865 fusion proteins Human genes 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 244000191761 Sida cordifolia Species 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 238000010367 cloning Methods 0.000 claims description 4
- 230000036039 immunity Effects 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 230000007910 cell fusion Effects 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 2
- 108010024636 Glutathione Proteins 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 206010068676 Pneumoretroperitoneum Diseases 0.000 claims description 2
- 208000005727 Retropneumoperitoneum Diseases 0.000 claims description 2
- 229920002684 Sepharose Polymers 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 239000002299 complementary DNA Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 2
- 239000000568 immunological adjuvant Substances 0.000 claims description 2
- 239000007928 intraperitoneal injection Substances 0.000 claims description 2
- 238000011068 loading method Methods 0.000 claims description 2
- 210000002826 placenta Anatomy 0.000 claims description 2
- 229940016590 sarkosyl Drugs 0.000 claims description 2
- 108700004121 sarkosyl Proteins 0.000 claims description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- 238000002525 ultrasonication Methods 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims 2
- 238000002038 chemiluminescence detection Methods 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 238000000502 dialysis Methods 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 13
- 239000000047 product Substances 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 210000004988 splenocyte Anatomy 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100372758 Danio rerio vegfaa gene Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010041308 Endothelial Growth Factors Proteins 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 101150030763 Vegfa gene Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940100684 pentylamine Drugs 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000000107 tumor biomarker Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510115025.0A CN104711279B (zh) | 2015-03-17 | 2015-03-17 | 一种血管内皮生长因子检测试剂盒及其原料制备 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510115025.0A CN104711279B (zh) | 2015-03-17 | 2015-03-17 | 一种血管内皮生长因子检测试剂盒及其原料制备 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104711279A CN104711279A (zh) | 2015-06-17 |
CN104711279B true CN104711279B (zh) | 2018-03-02 |
Family
ID=53410997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510115025.0A Expired - Fee Related CN104711279B (zh) | 2015-03-17 | 2015-03-17 | 一种血管内皮生长因子检测试剂盒及其原料制备 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104711279B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107167588A (zh) * | 2017-03-28 | 2017-09-15 | 马杰 | 用于检测血清中血管内皮生长因子的抗体及试剂盒 |
CN107941791B (zh) * | 2017-12-21 | 2020-09-11 | 江苏泽成生物技术有限公司 | 一种癌坯抗原校准品检验方法 |
CN109557320A (zh) * | 2018-11-26 | 2019-04-02 | 余波澜 | 辅助检测胎盘植入的试剂盒及其应用 |
CN110004170B (zh) * | 2019-04-10 | 2021-05-07 | 潍坊医学院 | 含有人smim25基因的重组质粒、基因工程菌、重组蛋白、多抗及制备方法和应用 |
CN110082537A (zh) * | 2019-04-17 | 2019-08-02 | 迪瑞医疗科技股份有限公司 | 血管内皮生长因子化学发光免疫检测试剂盒及其制备方法 |
CN111044734A (zh) * | 2019-12-30 | 2020-04-21 | 上海复星长征医学科学有限公司 | 一种用于检测血管内皮生长因子的检测试剂盒及其制备方法和使用方法 |
CN113214358B (zh) * | 2020-04-17 | 2022-03-15 | 青岛大学 | 一种短肽、检测试剂盒及检测血管内皮生长因子的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101418042A (zh) * | 2007-10-24 | 2009-04-29 | 苏州思坦维生物技术有限责任公司 | 重组人血管内皮细胞生长因子的分离纯化、体外化学标记及其应用 |
CN101943702A (zh) * | 2010-07-29 | 2011-01-12 | 江苏省原子医学研究所 | 一种针对血管内皮生长因子受体-3的光激化学发光药物筛选试剂盒 |
EP1572169B1 (en) * | 2002-03-08 | 2013-07-17 | Shanghai Institutes for Biological Sciences, CAS | Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof |
CN103969447A (zh) * | 2014-05-21 | 2014-08-06 | 张从从 | 用于血管内皮生长因子定量测定试剂盒及其发光底物溶液 |
-
2015
- 2015-03-17 CN CN201510115025.0A patent/CN104711279B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1572169B1 (en) * | 2002-03-08 | 2013-07-17 | Shanghai Institutes for Biological Sciences, CAS | Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof |
CN101418042A (zh) * | 2007-10-24 | 2009-04-29 | 苏州思坦维生物技术有限责任公司 | 重组人血管内皮细胞生长因子的分离纯化、体外化学标记及其应用 |
CN101943702A (zh) * | 2010-07-29 | 2011-01-12 | 江苏省原子医学研究所 | 一种针对血管内皮生长因子受体-3的光激化学发光药物筛选试剂盒 |
CN103969447A (zh) * | 2014-05-21 | 2014-08-06 | 张从从 | 用于血管内皮生长因子定量测定试剂盒及其发光底物溶液 |
Non-Patent Citations (2)
Title |
---|
血管内皮细胞生长因子的表达及其单克隆抗体的制备;徐静等;《中国生物制品学杂志》;20081130;第21卷(第11期);第1002-1005页 * |
重组人 VEGF165的表达纯化及单抗的初步筛选;包欣晨等;《中国生物工程杂志》;20111231;第31卷(第9期);第43-47页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104711279A (zh) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104711279B (zh) | 一种血管内皮生长因子检测试剂盒及其原料制备 | |
WO2017107974A1 (zh) | 血清psmd4蛋白的检测试剂盒及其检测方法与应用 | |
CN108414766A (zh) | 用于定量检测糖尿病自身抗体的试剂盒及其应用 | |
CN101407541B (zh) | 变性变构型环瓜氨酸多肽、及其融合蛋白、抗体和试剂盒 | |
CN109580959B (zh) | 一种检测肝素结合性表皮生长因子的elisa试剂盒 | |
EP3361252A1 (en) | Pivka-ii assay method and method for manufacturing reagent or kit for pivka-ii immunoassay | |
CN109975536A (zh) | 抗缪勒激素胶乳增强比浊法检测试剂盒及其制备使用方法 | |
CN101833009A (zh) | 一种双抗体复合的视黄醇结合蛋白检测试剂盒 | |
CN104764888A (zh) | 一种抗环瓜氨酸肽抗体检测试剂盒 | |
CN104694478B (zh) | 抗人脂联素的单克隆抗体及其应用 | |
CN102121938A (zh) | 一种免疫学检测试剂盒及其制备和使用方法 | |
CN106918708A (zh) | 一种用于检测胰岛素的竞争法胶乳增强免疫透射比浊试剂盒 | |
BRPI0612666B1 (pt) | anticorpo monoclonal, suporte sólido, composição, linhagem de células de hibridoma, imunoensaios e kits para sua detecção e quantificação | |
CN108196061B (zh) | 一种基于单克隆抗体检测人pgrn的双夹心elisa试剂盒 | |
CN107045062A (zh) | 检测人ngal的胶体金免疫层析试纸条、试剂盒及其制备方法 | |
Wang et al. | Development of antibody arrays for monoclonal antibody higher order structure analysis | |
CN103969447A (zh) | 用于血管内皮生长因子定量测定试剂盒及其发光底物溶液 | |
CN111781372A (zh) | 一种基于混合抗体的α1-AT免疫比浊法检测试剂盒及其制备使用方法 | |
CN112094355B (zh) | 一种用于临床诊断的复合质控品及其制备方法 | |
CN110183530A (zh) | 瘦素免疫原、杂交瘤细胞、单克隆抗体、多克隆抗体及应用 | |
CN107478848B (zh) | 定量检测人NT-proBNP的试剂盒及其制备方法 | |
CN106554411A (zh) | 可用作标准物质的胱抑素c产品、其制备方法及其用途 | |
CN107746430B (zh) | 一种gp73 c端抗原的制备及其应用 | |
CN104297494B (zh) | 一种抗乙型肝炎病毒x蛋白抗体酶联免疫测定试剂盒及其制备方法 | |
EP1879029B1 (en) | A neuroglobin enzyme-linked immunodetection kit and the use of it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151222 Address after: Licang District of Shandong province 266199 fo Lu Zheng Qingdao City No. 17 building room 1126 Applicant after: Shandong Yida sailing Biological Technology Co.,Ltd. Address before: 102628 Beijing city Daxing District Jinyuan Road No. 32 Building 3 room 918 9 Applicant before: BEIJING YIDA QIHANG BIOLOGICAL SCIENCE & TECHNOLOGY CO.,LTD. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: Room 1126, No. 17 Zhengfo Road Complex Building, Licang District, Qingdao City, Shandong Province Patentee after: Shandong Yida Biotechnology Co.,Ltd. Address before: 266199 Room 1126, No. 17 Zhengfo Road Complex Building, Licang District, Qingdao City, Shandong Province Patentee before: Shandong Yida sailing Biological Technology Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A vascular endothelial growth factor detection kit and its raw material preparation Effective date of registration: 20210309 Granted publication date: 20180302 Pledgee: Qingdao urban and rural community construction financing Company limited by guarantee Pledgor: Shandong Yida Biotechnology Co.,Ltd. Registration number: Y2021370010008 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180302 |
|
CF01 | Termination of patent right due to non-payment of annual fee |